Skip to main content
Home
  • About Us
    • About Us
    • Mission & Values
    • Leadership
    • News
    • Careers
    • Partnerships
    • Support
    • Achievements
  • For Researchers
    • Clinical Trials
      • Allergy & Asthma
      • Autoimmune Disease
      • Transplantation
      • Type 1 Diabetes
    • Core Facilities
    • Lab Protocols
      • ITN Protocols
      • T1D Preclinical Consortium
    • Policies
      • Publications Policy
    • Proposals
      • Submit Proposal
      • Current RFPs
      • Past RFPs
    • Publications
    • TrialShare
    • Strategic Plans
      • Allergy
      • Autoimmune Disease
        • Type 1 Diabetes
      • Transplantation
  • For Patients
    • Allergy & Asthma
    • Autoimmune Disease
    • Transplantation
      • Kidney
      • Liver
    • Type 1 Diabetes
    • Clinical Trial Info
  • TrialShare
  • Contact
    • Contact Us
      • BRI - Seattle Office
      • UCSF - San Francisco Office
    • Media Inquiries
Home

Secondary links

  • Home
  • TrialShare
  • Member Portal
  • About Us
    • About Us
    • Mission & Values
    • Leadership
    • News
    • Careers
    • Partnerships
    • Support
    • Achievements
  • For Researchers
    • Clinical Trials
    • Core Facilities
    • Lab Protocols
    • Policies
    • Proposals
    • Publications
    • TrialShare
    • Strategic Plans
  • For Patients
    • Allergy & Asthma
    • Autoimmune Disease
    • Transplantation
    • Type 1 Diabetes
    • Clinical Trial Info
  • TrialShare
  • Contact
    • Contact Us
    • Media Inquiries

Primary links

  • About Us
  • Mission & Values
  • Leadership
  • News
  • Careers
  • Partnerships
  • Support
  • Achievements

"Mechanisms of Tolerance" Symposium at Annual FOCIS Meeting

June 25, 2014 --

The ITN is hosting a Member Society Symposium entitled “Mechanisms of Tolerance” on June 25th, 2014 (12:45-pm-4:45pm CT) during the annual Federation of Clinical Immunology Societies (FOCIS) meeting in Chicago,  IL. The symposium features talks on emerging hypotheses of immune tolerance mechanisms:

Engrafting Tolerance using Hematopoeitic Stem Cells

12:45-1:25pm

Non-Myeloablative Bone Marrow Transplantation and High Dose Post-Transplant Cyclophosphamide for Chimerism Induction and Renal Allograft Tolerance  - Lode Swinnen, MD, Johns Hopkins University

Getting the Balance Right – Tregulatory:Teffectors

1:25-2:05pm

A Method for Tracking Alloreative T cells and Deletional Tolerance - Megan Sykes, MD, Columbia University

2:05-2:45pm

Rebalancing the Immune System in Type 1 Diabetes with Alefacept: Putting Theory into Practice - Mark Rigby, MD, PhD, Indiana University

Exhaustion: A Route to Tolerance

3:25-4:05pm

The Spectrum of Activation, Exhaustion, and Senescence as it Relates to Tolerance  - Allan Kirk, MD, PhD, Duke University

4:05-4:45pm

Exhaustion: A Mechanism of Spontaneous Tolerance - Sandy Feng, MD, PhD, University of California, San Francisco

The full Member Society Symposium agenda can be seen here.

The Immune Tolerance Network and is sponsored by the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.

National Institute of Allergy and Infectious Diseases

Footer

  • Home
  • Sponsors
  • Careers
  • Contact
  • Search

© 2021 Immune Tolerance Network

  • Privacy
  • Terms of Use
  • Accessibility